These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 3002305)

  • 21. [Use of a simplified exercise test in the study of a beta-blocker].
    Julien D; Hardy P; Hugues FC; Marche J
    Arch Mal Coeur Vaiss; 1982 Feb; 75(2):205-11. PubMed ID: 6280633
    [No Abstract]   [Full Text] [Related]  

  • 22. Sildenafil in the treatment of Raynaud's phenomenon resistant to vasodilatory therapy.
    Fries R; Shariat K; von Wilmowsky H; Böhm M
    Circulation; 2005 Nov; 112(19):2980-5. PubMed ID: 16275885
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rapid eye movement sleep deprivation-induced down-regulation of beta-adrenergic receptors in the rat brainstem and hippocampus.
    Pedrazzoli M; Benedito MA
    Pharmacol Biochem Behav; 2004 Sep; 79(1):31-6. PubMed ID: 15388281
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Treatment of Raynaud's syndrome with calcium entry blockers].
    Shcherbakov AB; Guseva NG; Mach ES
    Ter Arkh; 1987; 59(4):89-92. PubMed ID: 3296288
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Beta-1 receptor mediation of renin secretion elicited by low-frequency renal nerve stimulation.
    Osborn JL; DiBona GF; Thames MD
    J Pharmacol Exp Ther; 1981 Feb; 216(2):265-9. PubMed ID: 6257884
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Raynaud's phenomenon: peripheral catecholamine concentration and effect of sympathectomy.
    Nielsen SL; Christensen NJ; Olsen N; Lassen NA
    Acta Chir Scand Suppl; 1980; 502():57-62. PubMed ID: 6941602
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reproducibility of cold provocation in patients with Raynaud's phenomenon.
    Wigley FM; Malamet R; Wise RA
    J Rheumatol; 1987 Aug; 14(4):751-5. PubMed ID: 3668980
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Insulin modulation of an endothelial nitric oxide component present in the alpha2- and beta-adrenergic responses in human forearm.
    Lembo G; Iaccarino G; Vecchione C; Barbato E; Izzo R; Fontana D; Trimarco B
    J Clin Invest; 1997 Oct; 100(8):2007-14. PubMed ID: 9329964
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Digital pressure and flow measurement upon local cooling in Raynaud's disease. Effect of naftidrofuryl.
    Bounameaux HM; Hellemans H; Verhaege R
    Int Angiol; 1986; 5(1):39-44. PubMed ID: 3734514
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Nicardipine in the treatment of Raynaud's phenomenon].
    Kahan A; Amor B; Menkès CJ
    Rev Rhum Mal Osteoartic; 1987 Jun; 54(6):487-90. PubMed ID: 3303287
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Beta adrenergically mediated release of renin in the dog is not confined to either beta-1 or beta-2 adrenoceptors.
    Olson RD; Nies AS; Gerber JG
    J Pharmacol Exp Ther; 1982 Sep; 222(3):606-11. PubMed ID: 6125584
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Experimental Chagas' disease: effects of propranolol upon cardiac beta-receptors.
    Fernández R; Enders J; Rivarola W; Palma J; Paglini P
    Acta Physiol Pharmacol Ther Latinoam; 1998; 48(2):93-8. PubMed ID: 9695881
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The usefulness of tilt testing with an intravenous beta-blocker in assessing the efficacy of long-term therapy in patients with vasovagal syncope.
    Gielerak G; Makowski K; Dłuzniewska E; Stec A; Cholewa M
    Kardiol Pol; 2003 Aug; 59(8):93-104; commentary 103-4. PubMed ID: 14560324
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Atenolol in hypertension: follow-up of patients crossed over to this agent from propranolol, pindolol or metoprolol.
    Frewin DB; Penhall RK; Leonello PP; Clapp RJ
    N Z Med J; 1980 Nov; 92(672):389-90. PubMed ID: 6937768
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Laser Doppler-recorded venoarteriolar reflex in Raynaud's phenomenon.
    Stoyneva Z
    Auton Neurosci; 2004 Nov; 116(1-2):62-8. PubMed ID: 15556839
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Endothelin-1 in pathogenesis of Raynaud's syndrome].
    Knapik-Kordecka M; Adamiec R; Ciosek W
    Pol Merkur Lekarski; 2001 Jun; 10(60):424-5. PubMed ID: 11503255
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypokalemia before induction of anesthesia and prevention by beta 2 adrenoceptor antagonism.
    Kharasch ED; Bowdle TA
    Anesth Analg; 1991 Feb; 72(2):216-20. PubMed ID: 1845926
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of presynaptic beta-receptors in Raynaud's disease.
    Brotzu G; Carboni MG; Falchi S; Montisci R; Petruzzo P
    Artery; 1985; 13(2):77-86. PubMed ID: 3002305
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The importance of presynaptic beta receptors in Raynaud's disease.
    Brotzu G; Falchi S; Mannu B; Montisci R; Petruzzo P; Staico R
    J Vasc Surg; 1989 Jun; 9(6):767-71. PubMed ID: 2542629
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Beta-blockers: a new therapeutic approach to Raynaud's disease.
    Brotzu G; Susanna F; Roberto M; Palmina P
    Microvasc Res; 1987 Mar; 33(2):283-8. PubMed ID: 2884554
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.